These authors contributed equally to this work.
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
Article first published online: 22 JAN 2013
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 5, Issue 3, pages 353–365, March 2013
How to Cite
Zhu, J., Zhou, L., Wu, G., Konig, H., Lin, X., Li, G., Qiu, X.-L., Chen, C.-F., Hu, C.-M., Goldblatt, E., Bhatia, R., Chamberlin, A. R., Chen, P.-L. and Lee, W.-H. (2013), A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med, 5: 353–365. doi: 10.1002/emmm.201201760
- Issue published online: 5 MAR 2013
- Article first published online: 22 JAN 2013
- Manuscript Revised: 27 NOV 2012
- Manuscript Accepted: 27 NOV 2012
- Manuscript Received: 19 JUL 2012
- Funded Access